Q1’23 revenues of ¥764 billion, +15% YoY & 2.6% QoQ. FY2022, revenues +13.2% to ¥2,859, net income +3.9% to ¥219.4. TTM P/E ~16 reflects past, not future as a healthcare and semi materials champion.
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.